Skip to main content
. 2022 May;14(5):1319–1331. doi: 10.21037/jtd-21-1713

Table 5. Determinants of intubation and mortality in patients admitted to ICU due to COVID-19.

Variables All Patients Intubation Survival status
Yes No P value Died Survived P value
N (%) 50 (100.0) 28 (56.0) 22 (44.0) 22 (44.0) 28 (56.0)
Age (years) 66.3±13.4 66.3±10.4 66.2±16.7 0.99 69.1±12.0 64.1±14.2 0.19
Sex, n (% women) 23 (46.0) 8 (28.6) 15 (68.2) 0.01 8 (36.4) 15 (53.6) 0.26
BMI (kg/m²) 31.4±7.4 31.7±7.2 30.9±7.9 0.70 32.6±7.8 30.4±7.1 0.29
ARDS, n (%)
   No ARDS 5 (10.0) 0 5 (22.7) 0.001 0 5 (17.9) 0.059
   Mild ARDS 3 (6.0) 1 (3.6) 2 (9.1) 0.58 0 3 (10.7) 0.25
   Moderate ARDS 9 (18.0) 1 (3.6) 8 (36.4) 0.007 2 (9.1) 7 (25.0) 0.27
   Severe ARDS 33 (66.0) 26 (92.9) 7 (31.8) <0.0001 20 (90.9) 13 (46.4) 0.001
pO2/FiO2 (mmHg)
   On admission 151±93 114±68 198±102 0.002 107±43 185±108 0.001
   After 24 h 137±72 114±46 167±88 0.015 104±32 164±84 0.001
   Lowest value 101±58 79±40 128±66 0.004 75±22 120±70 0.003
SOFA score
   On admission 5.6±2.9 6.2±2.7 4.8±2.5 0.06 6.2±2.8 5.1±2.5 0.17
   After 24 h 7.0±3.8 8.1±3.5 5.9±3.7 0.04 8.0±3.5 6.4±3.8 0.12
CCI 3.9±2.4 3.7±2.1 3.6±2.5 0.85 4.1±2.3 3.3±2.2 0.18
NIV prior to ICU, n (%) 23 (46.0) 16 (57.1) 7 (31.8) 0.09 13 (59.1) 10 (35.7) 0.15
   Days NIV prior to ICU 4.7±4.9 5.1±5.4 3.6±3.7 0.35 6.3±5.9 2.5±2.0 0.046
   Days NIV ≥5 prior to ICU, n (%) 7 (14.0) 5 (17.9) 2 (9.1) 0.44 6 (27.3) 1 (3.6) 0.035
Hospitalization prior to ICU, median (IQR) (days) 1 (0; 4) 2 (0; 4) 0 (0; 5) 0.32 2 (0; 7) 0 (0; 3) 0.083

Data were presented as mean ± standard deviation if not otherwise specified. ICU, intensive care unit; COVID-19, coronavirus disease 2019; BMI, body mass index; ARDS, acute respiratory distress syndrome; pO2, partial pressure of oxygen; FiO2, inspiratory oxygen fraction; SOFA, sepsis organ failure assessment; CCI, Charlson Comorbidity Index; NIV, non-invasive ventilation; IQR, interquartile range.